Active Ingredient: RIVAROXABAN
Proprietary Name: XARELTO
Dosage Form; Route of Administration: FOR SUSPENSION; ORAL
Strength: 1MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215859
Product Number: 001
Approval Date: Dec 20, 2021
Applicant Holder Full Name: JANSSEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
